Pancreatic Cancer North America

08/20/2026

When Leah Crescenzo started feeling like something was off with her body, she went to the doctor right away.

She was 52, active, healthy, and paid close attention to her health. But when she raised concerns, she was told it's probably just menopause.

Eventually she was in so much pain she ended up in the emergency room and soon after was diagnosed with stage 4 pancreatic cancer.

Reach Leah’s full story and how her family is fighting back:
https://www.pancreaticcancernorthamerica.ca/news/its-probably-just-menopause

It's Probably Just Menopause...

08/18/2026

A diagnosis under 55 brings distinct questions and hurdles. If you’re navigating pancreatic cancer during your younger years, there is a community ready to support you.

Join our bi-weekly online support circle to connect with peers who get it.

🗓 2nd & 4th Wednesday of every month
⏰ 1:00 – 2:30 PM EDT
📍 Online

Click the link in our linktree to register today or visit wellspring.ca/under55PCSC

07/29/2026

Registration for Run for Survival 2026 is officially OPEN! 🏃‍♀️🏃🏾‍♂️🏃🏽

Join us in Calgary, Edmonton, or Mississauga to help outpace pancreatic cancer statistics.

Use code SURVIVAL at checkout before July 31 for a community discount + claim exclusive merch & perks! 🎟️✨ Register today to be part of the first 100 in your city and be entered into a draw to win a $100 gift card. Check out thesurvivalseries.org to register!

07/20/2026

By 2030, pancreatic cancer is projected to become the second-deadliest cancer in North America.

We refuse to sit around and let that happen.

Introducing the PCNA Survival Series: one platform, one movement, and one way to get louder in the fight for survival. Run, ride, host, fundraise, or donate in honour of someone you love, someone you miss, or someone still fighting.

This October, Run for Survival returns to Edmonton and expands to Calgary and Mississauga. And this is only the beginning. Sign up today and use code SURVIVAL for a discount on your registration until July 31, 2026.

Learn more and get involved: https://give.pancreaticcancercanada.ca/survivalseries

07/15/2026

“The biggest breakthrough ever in pancreas cancer.”

That is how Dr. Jennifer Knox of Princess Margaret Cancer Centre described Daraxonrasib in a recent interview.

For decades, pancreatic cancer has been left behind. Too many patients have had too few options.

Daraxonrasib, developed by , targets RAS, a key driver behind the growth and aggressiveness of most pancreatic cancers. Dr. Knox described RAS as the master switch, this drug is designed to turn that switch off. The early data showed survival was extended by 6 months in metastatic pancreatic cancer.

The drug has not yet been approved for use in Canada. That is unacceptable. The science is moving. Access needs to move faster.

PCNA is pushing for faster access, stronger clinical trial pathways, better treatment options, and earlier detection so more patients can benefit from breakthroughs in time. This is how we move survival to years, not just months.

Watch the full CTV News interview:https://www.ctvnews.ca/video/2026/07/13/why-dont-canadians-have-access-to-a-groundbreaking-new-pancreatic-cancer-drug/

07/09/2026

Pancreatic cancer is finally getting the national attention it deserves. 

A recent article highlights the urgent reality facing patients in Canada: major treatment advances like Daraxonrasib, developed by , are moving forward, but access is still out of reach for many who cannot afford to wait. 

For people facing pancreatic cancer, time is everything. 
The article features PCNA partner and advocate Jen Lovrics, whose husband Connor was part of the early clinical trial for Daraxonrasib. The drug gave him about six extra months in the best health he had experienced since his diagnosis, time spent skiing, swimming, travelling, and making memories with his young children. 

PCNA CEO Michelle Capobianco said it clearly: “The reality, still, is that early detection is the only solution for pancreatic cancer. We’re looking for six years, not just six months.” 
Breakthroughs in treatment matter. But patients need to be diagnosed early enough to benefit from them. 

That is why PCNA is focused on early detection. This is how we shift survival from months to years. 

Donate to support early detection research at the link in our bio.

07/03/2026

Last week, we were at the BIO International Convention joining biotech leaders from over 70 countries.

A powerful takeaway from the convention? Early detection in hard-to-treat cancers like pancreatic cancer is a consistent focus across the global oncology ecosystem, alongside advances in treatment and continued focus on better biomarkers and tools to improve patient outcomes.

Detecting this disease early is what gives patients the best opportunity to benefit from these emerging breakthroughs. We are dedicated to driving the investment and awareness needed to keep pancreatic cancer at the center of these critical global conversations and ultimately move survival from months to years.

06/21/2026

Father’s Day can be a difficult day to get through when you’re facing the emptiness of a dad’s absence, or the heavy burden of a new diagnosis.

When Gordon was diagnosed with pancreatic cancer, his wife Pam and daughter Tammy saw their world change overnight. Pam immediately became his full-time caregiver and researcher, looking for any shred of hope for their family. To gain more time, Gordon underwent the Whipple procedure—a complex, major surgery that only a small minority of pancreatic cancer patients are even eligible to receive.

Despite his incredible courage, the disease took Tammy’s dad just nine months later. Pam and Tammy channeled their profound grief into a shared mission. Together, they launched “Purple Pansies for Pancreatic Cancer.”

What started as a small grassroots effort between mother and daughter has grown into a powerful fundraiser, raising over $100,000 to fund the research and early detection that families like theirs so desperately need.

To everyone just trying to get through today: we see you, and we carry this grief with you. Dads like Gordon, and the families behind them, are why we need early detection and better treatment options now.

06/04/2026

For the first time, pancreatic cancer is gaining meaningful attention. We have seen this pattern in other cancers: when visibility rises, investment accelerates, and survival rates improve.

This is the moment we cannot afford to miss. Without sustained investment and focus to keep pancreatic cancer in the spotlight, progress will stall, and funding will continue to lag behind more visible diseases. Let's not lose momentum now.

05/26/2026

Sometimes, what matters most is talking to someone who understands.

Through our partnership with , people affected by pancreatic cancer can access one-to-one peer support from trained volunteers with lived experience. It is a space for connection, understanding, and support when it’s needed most.

At this time, Wellspring is prioritizing volunteers who are living with pancreatic cancer or actively caregiving, so support can reflect the needs of those navigating a current diagnosis.

If pancreatic cancer has touched your life, you don’t have to carry it alone.

Apply to become a volunteer here: https://forms.office.com/pages/responsepage.aspx?id=ezWQPvMm_Eqh229MQ2TijaYtaeorkg9OiFlazdRHWB9URU5ORkg1NUxONkRINFVNVDBQWjk3SzE3WiQlQCN0PWcu&origin=lprLink&route=shorturl